Venlafaxine Hydrochloride
- Product NDC
- 71335-1868
- 11-digit product format
- 713351868
- Labeler code
- 71335
- Product ID
- 71335-1868_7e6b92dd-caad-4a67-9013-4c0be2e20a60
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Venlafaxine Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA212277
- Marketing category
- ANDA
- Marketing start
- 2019-07-08
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Venlafaxine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VENLAFAXINE HYDROCHLORIDE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7D7RX5A8MO |
| Rxcui | 313585 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-1868-1 | 2024-11-19 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-2 | 2024-11-19 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-3 | 2024-11-19 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-4 | 2024-11-19 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-5 | 2024-11-19 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
| 71335-1868-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3916-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. VENLAFAXINE HYDROCHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1997 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-1868-1 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | | 102 |
| 71335-1868-2 | Venlafaxine Hydrochloride | 60 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 60 | | 102 |
| 71335-1868-3 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 102 |
| 71335-1868-4 | Venlafaxine Hydrochloride | 100 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 100 | | 102 |
| 71335-1868-5 | Venlafaxine Hydrochloride | 7 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 7 | | 102 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-1868 | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 102 | Current NDC, Legacy NDC, 5 package rows | 20241121_20a7d922-7f7c-4de4-b5fd-55c13aab060c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1868-1 | 71335186801 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1868-1) | 2021-06-22 | 0000-00-00 | No | No | Current |
| 71335-1868-2 | 71335186802 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1868-2) | 2024-10-11 | 0000-00-00 | No | No | Current |
| 71335-1868-3 | 71335186803 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1868-3) | 2021-06-11 | 0000-00-00 | No | No | Current |
| 71335-1868-4 | 71335186804 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1868-4) | 2024-10-31 | 0000-00-00 | No | No | Current |
| 71335-1868-5 | 71335186805 | 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-1868-5) | 2024-10-31 | 0000-00-00 | No | No | Current |